60 Percent of Nursing Home Workers in Ohio Decline COVID-19 Vaccines Over Safety Concerns

In a news briefing on Dec. 30, 2020, Ohio’s Governor Mike DeWine said that 60 percent of the nursing home staff in his state are refusing to get COVID-19 vaccines. According to surveys, health care workers in the United States have expressed fears of potentially dangerous side effects from the experimental vaccines and concerns about […]
Many Health Care Workers Concerned About Safety of COVID-19 Vaccines

Story Highlights Many health care workers are hesitant to get the experimental COVID-19 vaccines. One of the most common reasons given by health care workers for not getting the vaccine is a lack of data on the long-term effects of the vaccine. The CDC reported that addressing vaccine hesitancy among health care workers is their […]
Over 3,000 “Health Impact Events” After COVID-19 mRNA Vaccinations

Between Dec. 11 and 18, 2020, the U.S. Food and Drug Administration (FDA) granted Pfizer/BioNTech and Moderna pharmaceutical companies an Emergency Use Authorization (EUA)1 to distribute COVID-19 vaccines using messenger RNA (mRNA) technology that to date has not been licensed for use in humans.2 3 4 5 Although the Advisory Committee on Immunization Practices (ACIP) […]
Severe Allergic Reactions Reported After Pfizer/BioNTech COVID-19 Vaccinations

Last week the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA) issued a strong warning to those who have a history of significant allergic reactions to medicines, foods or vaccines or who carry an epi-pen that they may be at increased individual risk for suffering a serious allergic reaction after receiving the Pfizer/BioNTech COVID-19 […]
Brazil Halts and Re-Starts Phase 3 Clinical Trials of Chinese COVID-19 Vaccine

Brazil briefly stopped clinical trials of CoronaVac, the Chinese-made experimental vaccine for COVID-19, after a death among trial participants was reported on Nov 9, 2020. The Bhutantan Institute in San Paulo, Brazil had been conducting Phase 3 trials with more than 10,000 volunteers when the study was halted.1 However, within days, Bhutantan officials announced they […]
Pfizer CEO Sells Stock Same Day Positive Results of COVID-19 Vaccine Announced

Story Highlights On Nov. 9, 2020, Pfizer released preliminary Phase 3 clinical trial data indicating that its experimental mRNA COVID-19 vaccine is 90 percent effective, triggering a big surge in stock price. Pfizer CEO Albert Bourla immediately sold 60 percent of his company stock, realizing a gain of $5.6 million in what the company called […]
